Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study

References

• Klein R, Wang Q, Klein BEK, Moss SE, Meuer SM. The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci. 1995;36:182-9I.
   Google Scholar
• Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Arch Ophthalmol. 1994;I 12:500–9.
   Google Scholar
• Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997; 277:1805–7.
   PubMed Web of Science ®Google Scholar
• Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol. 1994;11: 51–67.
   PubMed Web of Science ®Google Scholar
• Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, et al. The epsilon 4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. Am J Ophthalmol. 1998;125:353–9.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women. J Am Med Assoc. 1996;276:1141–6.
   PubMed Web of Science ®Google Scholar
• Delcourt C, Diaz JL, Ponton-Sanchez A, Papoz L, the POLA Study Group. Smoking and age-related macular degeneration: The POLA study. Arch Ophthalmol. 1998;116:1031–5.
   Google Scholar
• Gerster H. Review: Antioxidant protection of the ageing macula. Age Ageing. 1991;20:60–9.
   PubMed Web of Science ®Google Scholar
• Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124:677–82.
   PubMed Web of Science ®Google Scholar
• Kahn HA, Leibowitz HM, Ganley JP, Kini MIVI, Colton T, Nickerson RS, et al. The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study. Am J Epidemiol. 1977;106:33–41.
   Google Scholar
• Sperduto RD, Hiller R. Systemic hypertension and age-related maculopathy in the Framingham Study. Arch Ophthalmol. 1986;104: 216–9.
   PubMedGoogle Scholar
• Goldberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 1988;128: 700–10.
   Google Scholar
• Klein R, Klein BEK, Franke T. The relationship of cardiovascular disease and its risk factors to age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1993;100:406–14.
   Google Scholar
• Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, De Jong PT, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol. 1995;142: 404–9.
   Google Scholar
• Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: The Blue Mountains Eye Study. Arch Ophthalmol. 1998;116:583–7.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99: 933–43.
   Google Scholar
• Friedman DS, Katz J, Bressler NM, Rahmani B, Tielsch JM. Racial differences in the prevalence of age- related macular degeneration — The Baltimore eye survey. Ophthalmology. 1999;106: 1049–55.
   Google Scholar
• Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102: 205–10.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995;102: I 450–60.
   Web of Science ®Google Scholar
• Klein R, Klein BEK, Jensen SC, Maresperlman JA, Cruickshanks KJ, Palta M, et al. Age-related maculopathy in a multiracial United States population — The national health and nutrition examination survey III. Ophthalmology. 1999;106: 1056–65.
   PubMed Web of Science ®Google Scholar
• Delcourt C, Cristol JP, Tessier F, Leger CL, Michel F, Papoz L, et al. Risk factors for cortical, nuclear, and posterior subcapsular cataracts: the POLA Study. Pathologies oculaires liées A PAge. Am J Epidemiol. 2000;151:497–504.
   PubMed Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–74.
   PubMed Web of Science ®Google Scholar
• Klein R, Davis MD, Magli YL, Segal P, Klein BEK, Hubbard L, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991;98:1128–34.
   PubMed Web of Science ®Google Scholar
• Maltzman BA, Mulvihill MN, Greenbaum A. Senile macular degeneration and risk factors: a case-control study. Ann Ophthalmol. 1979;11:1197–201.
   Google Scholar
• Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1992;110:1701–8.
   PubMed Web of Science ®Google Scholar
• Vinding T, Appleyard M, Nyboe J, Jensen G. Risk factor analysis for atrophic and exudative age-related macular degeneration. An epidemiological study of moo aged individuals. Acta Ophthalmol. (Copenh) 1992;70:66–72.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK, Jensen SC. The relation of cardiovascular disease and its risk factors to the 5-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104: 1804–12.
   Google Scholar
• Klein R, Clegg L, Cooper LS, Hubbard LD, Klein BEK, King WN, et al. Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study. Arch Ophthalmol. 1999;117: 1203–10.
   PubMedGoogle Scholar
• Delaney WV Jr, Oates RP. Senile macular degeneration: a preliminary study. Ann Ophthalmol. 1982;14: 21–4.
   PubMedGoogle Scholar
• Vidaurri JS, Pe'Er J, Halfon ST, Halperin G, Zauberman H. Association between drusen and some of the risk factors for coronary artery disease. Ophthalmologica. 1984;188:243–7.
   Google Scholar
• Hirvela H, Luukinen H, Laara E, SeL, Laatikainen L. Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology. 1996;103: 871–7.
   Google Scholar
• Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, et al. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med. 1999;340:1221–7.
   PubMed Web of Science ®Google Scholar
• Mulrow PJ. Detection and control of hypertension in the population: the United States experience. Am J Hypertens. 1998; II:744–6.
   Google Scholar
• Gasse C, Stieber J, Doring A, Kiel U, Hense HW. Population trends in antihypertensive drug use: results from the MONICA Augsburg Project 1984 to 1995. J Clin Epidemiol. 1999;52: 695–703.
   Google Scholar
• Blumenkranz MS, Russell SR, Robey MG, Kott Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology. 1986;93:552–8.
   Google Scholar
• Klein R, Klein BEK, Moss SE. Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1527–34.
   Google Scholar
• Klaver CCW, Kliffen M, Vanduijn CM, Hofman A, Cruts M, Grobbee DE, et al. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998;63:200–6.
   PubMed Web of Science ®Google Scholar
• Howard BY, Gidding SS, Liu K. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA Study. Am J Epidemiol. 1998;148:859–68.
   Google Scholar
• Stengard JH, Pekkanen J, Ehnholm C, Nissinen A, Sing CE Genotypes with the apolipoprotein epsilon 4 allele are predictors of coronary heart disease mortality in a longitudinal study of elderly Finnish men. Hum Genet. 1996;97:677–84.
   PubMed Web of Science ®Google Scholar
• Robitaille N, Cormier G, Couture R, Bouthillier D, Davignon J, Perusse L, et al. Apolipoprotein E polymorphism in a French Canadian population of northeastern Quebec: allele frequencies and effects on blood lipid and lipoprotein levels. Hum Biol. 1996;68:357–70.
   PubMed Web of Science ®Google Scholar
• Price JF, Fowkes FGR. Antioxidant vitamins in the prevention of cardiovascular disease. The epidemiological evidence. Eur Heart J. 1997;18:719–27.
   PubMed Web of Science ®Google Scholar
• Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L, et al. Age-related macular degeneration and antioxidant status in the POLA study. Pathologies oculaires liees a l'age. Arch Ophthalmol. 1999;117:1384–90.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BEK, Linton KL, Demets DL. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol. 1993;137:190–200.
   PubMed Web of Science ®Google Scholar
• Vingerling JR, Hofman A, Grobbee DE, De Jong PT. Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol. 1996;114: 1193–6.
   Google Scholar
• Smith W, Mitchell P, Leeder SR. Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1996;114:1518–23.
   Google Scholar